Prevention and management of lung cancer in China

Lung cancer is the leading cause of cancer‐related death worldwide. In China, the incidence of lung cancer has grown rapidly, resulting in a large social and economic burden. Several researchers have devoted their studies to lung cancer and have demonstrated that there are many risk factors for lung cancer in China, including tobacco use, environmental pollution, food, genetics, and chronic obstructive pulmonary disease. However, the lung cancer incidence is still growing rapidly in China, and there is an even higher incidence among the younger generation. One explanation may be the triple‐neglect situation, in which medical policies that neglect prevention, diagnosis, and supportive care have increased patients' mortality and reduced their quality of life. Therefore, it is necessary to enhance the efficiency of prevention and early diagnosis not only by focusing more attention on treatment but also by drawing more attention to supportive care for patients with lung cancer. Cancer 2015;121:3080‐8. © 2015 American Cancer Society.

[1]  P. Prorok,et al.  Prior lung disease and lung cancer risk in an occupational-based cohort in Yunnan, China. , 2011, Lung cancer.

[2]  Guo Bin.  Status Quo and Issues of Direct Impatient Cost of Lung Carcinoma in China , 2007 .

[3]  Wanqing Chen.  [Estimation of cancer incidence and mortality in China in 2004-2005]. , 2009, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[4]  Ying Cheng,et al.  Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial. , 2013, The Lancet. Oncology.

[5]  Jie He,et al.  Annual report on status of cancer in China, 2011. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[6]  H. Ji,et al.  Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[8]  Jin Yong-chun.  Study on the Economic Burden of Lung Cancer Inpatients from One Tertiary Hospital in Shanghai , 2012 .

[9]  Na Liu,et al.  [Smoking and passive smoking in Chinese, 2002]. , 2005, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[10]  Hong-wei Zhang,et al.  [A cross sectional study of passive smoking of non-smoking women and analysis of influence factors on women passive smoking]. , 2006, Wei sheng yan jiu = Journal of hygiene research.

[11]  Jun Ma,et al.  Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. , 2011, The Lancet. Oncology.

[12]  Wanqing Chen,et al.  1989年-2008年中国肺癌发病性别、城乡差异及平均年龄趋势分析 , 2013, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[13]  Wen Tan,et al.  A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese , 2011, Nature Genetics.

[14]  Jixiang Ma,et al.  Economic burden of malignant neoplasms in Shandong province , 2010 .

[15]  Tong Zhu,et al.  Environmental health in China: progress towards clean air and safe water , 2010, The Lancet.

[16]  C. Bai,et al.  Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population , 2013, Respirology.

[17]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[18]  T. Mok,et al.  Research and standard care: lung cancer in china. , 2012, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[19]  J Zhang,et al.  Multicenter analysis of lung cancer patients younger than 45 years in Shanghai , 2010, Cancer.

[20]  Caicun Zhou.  Lung cancer molecular epidemiology in China: recent trends. , 2014, Translational lung cancer research.

[21]  Kurt Straif,et al.  Carcinogenicity of household solid fuel combustion and of high-temperature frying. , 2006, The Lancet. Oncology.

[22]  Min Dai,et al.  中国省区水平肺癌死亡率估计方法研究 , 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[23]  C. Bai,et al.  The prevalence of undiagnosed and undertreated COPD in lung cancer population , 2012 .

[24]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[25]  J. Lubin,et al.  Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. , 2001, International journal of epidemiology.

[26]  S R Leeder,et al.  Smoking and passive smoking. , 1987, Australian family physician.

[27]  T. Hu,et al.  When a tax increase fails as a tobacco control policy: the ITC China project evaluation of the 2009 cigarette tax increase in China , 2011, Tobacco Control.

[28]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[29]  Tao Lu-ning.  Trends of Clinical Features and Direct Medical Costs in Patients With Lung Cancer from 2000 to 2009 , 2013 .

[30]  M. Dai,et al.  [Estimates and prediction on incidence, mortality and prevalence of lung cancer in China in 2008]. , 2012, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[31]  Yang Shuanying.  The status quo,confusion and prospect of early diagnosis for lung cancer , 2011 .

[32]  I. Katz,et al.  Tobacco tightrope--balancing disease prevention and economic development in China. , 2007, The New England journal of medicine.

[33]  T. Mok,et al.  Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. , 2009, The New England journal of medicine.

[34]  S. Tao,et al.  Inhalation exposure to ambient polycyclic aromatic hydrocarbons and lung cancer risk of Chinese population , 2009, Proceedings of the National Academy of Sciences.